TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
15 hedge funds and large institutions have $2.81M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$53.3K | |
| 2 | +$30.1K | |
| 3 | +$25K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.36K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.3K |
Top Sellers
| 1 | -$899K | |
| 2 | -$292K | |
| 3 | -$156K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$65K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$43K |